It is also generally believed that tumor cells may adapt to oncogene-induced RS by modulating the intensity of the ATR–Claspin–Chk1 response [94,112,113], as ATR and Chk1 haploinsufficiencies enhance oncogene-induced tumor development [114,115]. This evidence concerns the gene CLSPN and neoplasm.